Quest Diagnostics Incorporated
DGX Healthcare Diagnostics & Research
Quest Diagnostics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $11.0 billion, up 11.8% from fiscal 2024. In the quarter to June 2026, revenue grew 10.2%, EPS grew 14.7%, free cash flow grew 5.28% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.
Follow DGX
Quest Diagnostics Incorporated (DGX) Total debt
Quest Diagnostics Incorporated's total debt at the end of fiscal 2025 was $5.7B, down 8.78% from $6.2B in fiscal 2024. At the end of the quarter to 30 June 2026 it was $5.6B. Over the past ten years it has ranged from $3.7B (fiscal 2015) to $6.2B (fiscal 2024); the current reading is higher than 91% of that period. Quest Diagnostics Incorporated ranks 5th of 50 Diagnostics & Research companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $5.7B | (8.78%) |
| FY2024 | $6.2B | 31.91% |
| FY2023 | $4.7B | 18.42% |
| FY2022 | $4.0B | (0.80%) |
| FY2021 | $4.0B | (0.07%) |
| FY2020 | $4.0B | (15.83%) |
| FY2019 | $4.8B | 22.53% |
| FY2018 | $3.9B | 2.88% |
| FY2017 | $3.8B | 1.34% |
| FY2016 | $3.7B | 2.27% |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Jun 2026 | $5.6B | (0.28%) |
| Mar 2026 | $5.7B | (0.23%) |
| Dec 2025 | $5.7B | (0.07%) |
| Sep 2025 | $5.7B | 0.04% |
| 42 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| LH Labcorp Holdings Inc. compare | $5.9B |
| DGX Quest Diagnostics Incorporated | $5.6B |
| WAT Waters Corporation compare | $4.9B |
| RVTY Revvity Inc. compare | $3.2B |
| MTD Mettler-Toledo International, Inc. compare | $2.1B |
| GH Guardant Health, Inc. compare | $1.5B |
| ILMN Illumina, Inc. compare | $1.5B |
| IDXX IDEXX Laboratories, Inc. compare | $449.9M |
| MEDP Medpace Holdings, Inc. compare | $163.0M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on DGX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement